Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells

Christine Dufès, Majed Al Robaian, Sukrut Somani

Research output: Contribution to journalArticle

  • 47 Citations

Abstract

The potential use of many promising novel drugs is limited by their inability to specifically reach their site of action after intravenous administration, without secondary effects on healthy tissues. In order to remediate this problem, the protein transferrin (Tf) has been extensively studied as a targeting molecule for the transport of drug and gene delivery systems to the brain and cancer cells. A wide range of delivery approaches have been developed to target the Tf receptor and they have already improved the specific delivery of Tf-bearing therapeutic agents to their site of action. This review provides a summary of the numerous delivery strategies used to target the Tf receptor and focuses on recent therapeutic advances.
LanguageEnglish
Pages629-640
Number of pages12
JournalTherapeutic Delivery
Volume4
Issue number5
DOIs
StatePublished - 7 May 2013

Fingerprint

Transferrin Receptors
Transferrin
Brain Neoplasms
Gene Transfer Techniques
Drug Delivery Systems
Intravenous Administration
Therapeutics
Pharmaceutical Preparations
Proteins

Keywords

  • transferrin
  • delivery systems
  • tumor targeting
  • brain delivery
  • blood-brain barrier
  • receptor
  • cancer cells

Cite this

@article{2dd522f002e54541bc941bac47b3d349,
title = "Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells",
abstract = "The potential use of many promising novel drugs is limited by their inability to specifically reach their site of action after intravenous administration, without secondary effects on healthy tissues. In order to remediate this problem, the protein transferrin (Tf) has been extensively studied as a targeting molecule for the transport of drug and gene delivery systems to the brain and cancer cells. A wide range of delivery approaches have been developed to target the Tf receptor and they have already improved the specific delivery of Tf-bearing therapeutic agents to their site of action. This review provides a summary of the numerous delivery strategies used to target the Tf receptor and focuses on recent therapeutic advances.",
keywords = "transferrin , delivery systems, tumor targeting, brain delivery , blood-brain barrier, receptor, cancer cells",
author = "Christine Duf{\`e}s and {Al Robaian}, Majed and Sukrut Somani",
year = "2013",
month = "5",
day = "7",
doi = "10.4155/tde.13.21",
language = "English",
volume = "4",
pages = "629--640",
journal = "Therapeutic Delivery",
issn = "2041-5990",
number = "5",

}

Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. / Dufès, Christine; Al Robaian, Majed; Somani, Sukrut.

In: Therapeutic Delivery, Vol. 4, No. 5, 07.05.2013, p. 629-640.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells

AU - Dufès,Christine

AU - Al Robaian,Majed

AU - Somani,Sukrut

PY - 2013/5/7

Y1 - 2013/5/7

N2 - The potential use of many promising novel drugs is limited by their inability to specifically reach their site of action after intravenous administration, without secondary effects on healthy tissues. In order to remediate this problem, the protein transferrin (Tf) has been extensively studied as a targeting molecule for the transport of drug and gene delivery systems to the brain and cancer cells. A wide range of delivery approaches have been developed to target the Tf receptor and they have already improved the specific delivery of Tf-bearing therapeutic agents to their site of action. This review provides a summary of the numerous delivery strategies used to target the Tf receptor and focuses on recent therapeutic advances.

AB - The potential use of many promising novel drugs is limited by their inability to specifically reach their site of action after intravenous administration, without secondary effects on healthy tissues. In order to remediate this problem, the protein transferrin (Tf) has been extensively studied as a targeting molecule for the transport of drug and gene delivery systems to the brain and cancer cells. A wide range of delivery approaches have been developed to target the Tf receptor and they have already improved the specific delivery of Tf-bearing therapeutic agents to their site of action. This review provides a summary of the numerous delivery strategies used to target the Tf receptor and focuses on recent therapeutic advances.

KW - transferrin

KW - delivery systems

KW - tumor targeting

KW - brain delivery

KW - blood-brain barrier

KW - receptor

KW - cancer cells

U2 - 10.4155/tde.13.21

DO - 10.4155/tde.13.21

M3 - Article

VL - 4

SP - 629

EP - 640

JO - Therapeutic Delivery

T2 - Therapeutic Delivery

JF - Therapeutic Delivery

SN - 2041-5990

IS - 5

ER -